We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALGN icon
401
Align Technology
ALGN
$9.99B
$2.34M 0.04%
+11,074
New +$2.22M
2022 Q4
0 quarters
EONR icon
402
EON Resources
EONR
$26.1M
$2.33M 0.04%
227,558
-2,227
-1% -$22.5K
2022 Q2
2 quarters
FLD icon
403
Fold Holdings
FLD
$29.1M
$2.32M 0.04%
231,686
-2,267
-1% -$22.5K
2022 Q1
3 quarters
TRCA
404
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
$2.32M 0.04%
230,062
-2,300
-1% -$23K
2021 Q2
6 quarters
PICC
405
DELISTED
Pivotal Investment Corporation III
PICC
$2.32M 0.04%
229,322
– –
2021 Q2
6 quarters
PSPC
406
DELISTED
Post Holdings Partnering Corporation
PSPC
$2.3M 0.04%
231,686
-2,267
-1% -$22.3K
2022 Q1
3 quarters
ALCE
407
DELISTED
Alternus Clean Energy Inc
ALCE
$2.3M 0.04%
9,102
-89
-1% -$22.2K
2022 Q2
2 quarters
WPCA
408
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$2.3M 0.04%
227,555
-2,227
-1% -$22.3K
2021 Q2
6 quarters
RARE icon
409
Ultragenyx Pharmaceutical
RARE
$1.51B
$2.3M 0.04%
+49,549
New +$1.95M
2022 Q4
0 quarters
BSLK
410
DELISTED
Bolt Projects Holdings
BSLK
$2.29M 0.04%
11,427
-112
-1% -$22.3K
2022 Q1
3 quarters
MTAL icon
411
DELISTED
Metals Acquisition
MTAL
$2.28M 0.04%
227,558
-2,227
-1% -$22.1K
2021 Q3
5 quarters
AXGN icon
412
Axogen
AXGN
$2.18B
$2.26M 0.04%
226,870
+1,393
+0.6% +$15.5K
2022 Q1
3 quarters
ADT icon
413
ADT
ADT
$4.72B
$2.23M 0.04%
246,182
+166,586
+209% +$1.48M
2018 Q2
18 quarters
OUT icon
414
Outfront Media
OUT
$5.32B
$2.23M 0.04%
+136,388
New +$2.3M
2022 Q4
0 quarters
LEN icon
415
Lennar Class A
LEN
$17.7B
$2.21M 0.04%
+25,282
New +$2.05M
2022 Q4
0 quarters
INBX icon
416
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.19M 0.04%
88,800
+17,503
+25% +$514K
2022 Q2
2 quarters
FNVT icon
417
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.19M 0.04%
212,681
-2,081
-1% -$21.1K
2021 Q4
4 quarters
KROS icon
418
Keros Therapeutics
KROS
$231M
$2.18M 0.04%
45,318
+11,997
+36% +$560K
2022 Q1
3 quarters
BLU
419
DELISTED
BELLUS Health Inc.
BLU
$2.17M 0.04%
264,249
+24,881
+10% +$232K
2022 Q1
3 quarters
DNAD
420
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.17M 0.04%
216,014
-2,114
-1% -$21K
2021 Q2
6 quarters
UDR icon
421
UDR
UDR
$10.9B
$2.16M 0.04%
+55,808
New +$2.2M
2022 Q4
0 quarters
TSLA icon
422
Tesla
TSLA
$1.49T
$2.16M 0.04%
17,526
-42,738
-71% -$8.09M
2021 Q2
6 quarters
CITE icon
423
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.16M 0.04%
208,518
-2,040
-1% -$20.9K
2022 Q2
2 quarters
CSIQ icon
424
Canadian Solar
CSIQ
$751M
$2.14M 0.04%
+69,219
New +$2.32M
2022 Q4
0 quarters
IMCR icon
425
Immunocore
IMCR
$1.5B
$2.13M 0.04%
37,252
+2,555
+7% +$144K
2022 Q1
3 quarters
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.